Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
 BACK TO LIST

Laboratory Report

Patient
Name: Fabbri, , Gioele,
DOB: 12-SEP-1972 (Age: 53)
Gender: male
Address:
Canale Armani, 25
23887 Revislate (Italy)
ID: 3631-767680-1 (ECI)
Report
Date: 24-SEP-2018
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Ospedale di Calcinate "F.M. Passi"
Piazza Ospedale 3
24050 Calcinate (Italy)
Specimen
Collected: 24-SEP-2018

Chemistry

Test 24-SEP-2018 Reference Range Unit
Cholesterol [Mass/volume] in Serum or Plasma 166.6 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 114.0 0 - 150 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 93.5 0 - 130 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 50.4 40 - 100 mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
All lipid parameters (total cholesterol, LDL, HDL, and triglycerides) are within normal limits. No laboratory evidence of dyslipidemia at this time. Recommend continued routine monitoring and maintenance of a healthy lifestyle.